Caffeine Kinetics and CrossFit®-Specific Performance

Launched by POZNAN UNIVERSITY OF PHYSICAL EDUCATION · Aug 23, 2022

Keywords

ClinConnect Summary

This clinical trial is looking at how caffeine affects performance in CrossFit® athletes. Researchers want to understand how quickly caffeine and its byproducts move through the body after taking a specific amount (3 mg per kilogram of body weight) and how this affects exercise performance and recovery. They will also check blood samples to see how caffeine influences muscle recovery and balance in the body. Additionally, the study will explore how certain genetic factors may affect how individuals process caffeine.

To participate in this trial, you need to be a male athlete aged between 65 and 74 years with at least five years of experience in any sport and two years in high-intensity functional training (HIFT). You should be training at least three times a week and compete in CrossFit® events at least once a year. Before joining, you’ll need to provide written consent and have medical clearance to ensure you can safely participate. Those with current injuries, serious health issues, or who have been unwell recently will not be eligible. If you join, you can expect to provide blood samples and follow specific guidelines throughout the study.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • written informed consent from all participants before the study,
• • a current medical clearance to practice sports,
• • training experience any sport discipline ≥ 5 years and training experience in HIFT ≥ 2 years,
• • performing ≥3 training units per week,
• • participating in CrossFit® competitions at least once a year.
• Exclusion Criteria:
• • current injury,
• • any health-related contraindication,
• • declared general feeling of being unwell,
• • unwilling to follow the study protocol,
• • serious disease or metabolic problems,
• • smoking and tobacco use,
• • presence of infectious disease in the previous 4 weeks of the study.